Charles Albright
2019
In 2019, Charles Albright earned a total compensation of $2M as Executive Vice President and Chief Scientific Officer at Editas Medicine, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $296,954 |
|---|---|
| Option Awards | $701,454 |
| Salary | $427,774 |
| Stock Awards | $562,078 |
| Other | $8,063 |
| Total | $1,996,323 |
Albright received $701.5K in option awards, accounting for 35% of the total pay in 2019.
Albright also received $297K in non-equity incentive plan, $427.8K in salary, $562.1K in stock awards and $8.1K in other compensation.
Rankings
In 2019, Charles Albright's compensation ranked 5,929th out of 13,971 executives tracked by ExecPay. In other words, Albright earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,929 out of 13,971 | 58th |
Division Manufacturing | 2,218 out of 5,695 | 61st |
Major group Chemicals And Allied Products | 803 out of 2,194 | 63rd |
Industry group Drugs | 678 out of 1,880 | 64th |
Industry Biological Products, Except Diagnostic Substances | 161 out of 389 | 59th |
Source: SEC filing on April 28, 2020.
Albright's colleagues
We found six more compensation records of executives who worked with Charles Albright at Editas Medicine in 2019.
2019
Cynthia Collins
Editas Medicine
Chief Executive Officer
2019
Judith Abrams
Editas Medicine
Chief Medical Officer
2019
Vic Myer
Editas Medicine
Chief Technology Officer
2019
Eric Ek
Editas Medicine
Chief Financial Officer
2019
Katrine Bosley
Editas Medicine
Chief Executive Officer
2019
Andrew Hack
Editas Medicine